Thus, USP22 has been proposed as an attractive therapeutic target in malignant diseases and, indeed, there is ongoing research to generate and optimize USP22 inhibitors4, although caution must be used given our findings of the context-dependent function of USP22 in cancer. This evidence concerns the gene USP22 and cancer.